S10 Ep23: Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa

OncLive® On Air

English - March 28, 2024 18:00 - 15 minutes - 13.9 MB - ★★★★ - 19 ratings
Health & Fitness Science Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: S10 Ep22: CRC Experts Highlight AE Management and Prevention Strategies for TAS-102/Bevacizumab, Regorafenib, and Fruquintinib

Next Episode: S10 Ep24: Schmid Summarizes Updates in HER2-Positive Breast Cancer Management

Dr Wagner discusses current unmet needs for patients with PEComa, how ongoing research aims to address some of these gaps, and how findings from the AMPECT trial in particular support the use of nab-sirolimus in patients with advanced malignant disease.